• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer

ww.care

Real Care for Wounded Warriors Foundation Inc.

  • Donate

Tonix shares soar as PTSD drug shows promise in study – Reuters UK

May 19, 2016 08:06

Tonix shares soar as PTSD drug shows promise in study – Reuters UK


Reuters UK

Tonix shares soar as PTSD drug shows promise in study
Reuters UK
Tonix Pharmaceuticals Holding Corp said a higher dose of its experimental drug for post-traumatic stress disorder (PTSD) helped control symptoms in patients, sending its shares surging 46 percent in premarket trading. A 5.6 mg dose of the drug, TNX-102 …
Tonix Pharma’s PTSD candidate for shows positive effects in mid-stage study; shares up 20% premarketSeeking Alpha
Tonix Pharmaceuticals Reports Positive Topline Results from Phase 2 AtEase Study of TNX-102 SL in Post-Traumatic …GlobeNewswire (press release)
Tonix Pharmaceuticals Phase 2 trial success for military related PTSDProactive Investors USA & Canada

all 6 news articles »

Categories

  • PTSD
  • PTSD Community
  • PTSD Science
  • PTSD Treatment Cure Causes
  • Veterans PTSD

Archives

  • June 2016
  • May 2016
  • April 2016
  • About
  • For Scientists
  • Contact Us

2016-2021 Real Care for Wounded Warriors, A 501(c)3 organization. All donations are tax deductible.